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Dear Editor,
Drug administration can be a precarious process in in-
experienced hands. Inadequate operation theatre experi-
ence or insufficient familiarity with the drug delivery de-
vices, lack of plentiful supervision, or limited knowledge
about drugs being administered can all lead to administra-
tion of incorrect drugs to the patient. Even in experienced
hands, sometimes multiple factors dominate over com-
mon sense and expertise- like fatigue, sheer carelessness
or poor communication with the team, haste in an emer-
gency, poor labeling of drug, or distraction, which can lead
to erroneous administration of drugs to the patient. Re-
duced number of iatrogenic errors has always been an in-
dicator of excellence in anesthesia practice, and a signifi-
cant area of errors slithers in from prescribing medication
that looks or sounds like an entirely different medication.
There are standards of color coding in anesthesia for
cylinders, gas pipelines, intravenous cannulas to ensure
the safety of the patients, but alas, similar measures have
not been developed to prevent wrong administration of
look-alike drugs. In fact, different manufacturers use their
own will in labeling drugs, which may be accidentally
misleading- for example morphine sulfate may be con-
fused with morphine sulfate extended-release. Similarly,
dexamethasone may be confused as dextromethorphan,
oxycodone as oxycontin or tramadol as trazodone. In these
circumstances, a standard naming and packaging of drugs
become imperative, especially when different manufac-
turers manufacture multiple different drugs in the same
name, for example “Medzole” for midazolam, pantopra-
zole and metronidazole, esomeprazole, itraconazole, al-
bendazole, etc. (Figure 1). The errors are not just limited to
oral or intravenous administration. Many errors have also
occurred as drug administration in the intrathecal space,
for example tranexamic acid ampoule looks strikingly sim-
ilar to heavy bupivacaine, and has been administered acci-
dentally in the intrathecal space (1), leading to catastrophic
results.
According to 8th annual MEDMARX data report pub-
lished by United States pharmacopeia, there were 1470 dif-
ferent drugs, which are implicated in causing medication
errors due to similar brand and generic names and com-
piled a list of 3170 look alike and sound alike drugs (2).
The fear of administration of the wrong drug is not
only limited to due to similar labeling however, due to the
similar appearance of ampoules and vials too. This is very
common practice in anesthesia to pick similar looking am-
poules from the drug desk. When tired or during the wee
hours of an emergency duty, even the most conscientious
anesthetist can get unmindfully caught in such a situa-
tion. The mishaps of this nature have been seen since, ages
and it continues to be even reported in literature today (3).
Confusion between drugs arises from similar labeling and
packaging, color and size of ampoules, names of drugs,
strength and dosage forms, clinical use and frequency of
administration and incomplete knowledge of drug names.
The wrong drug administered as a result of human er-
ror can lead to complete therapeutic failure, serious tox-
icity, and unwarranted side effects and may even be fatal
for the patient. Simple vigilance is the minimum basic
step in avoiding any errors in the operation theater (OT)
and the intensive care unit (ICU). Often, the drug errors
that occur in the operating room cannot be reversed. How-
ever, prevention is the best cure for such lethal effects that
can occur because of drug administration. The following
strategies can be considered for preventing such errors.
Many disasters can be prevented if we have a standard-
ized system of coding, for example color coding of differ-
ent classes of drug ampoules according to an agreed na-
tional or international standard. Contents of labels on am-
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Figure 1. Multiple different drugs in the same name that manufactured by different manufacturers
poules and vials should be legible and must be standard-
ized for font, size, and color. Appropriate instructions from
drug regulatory authorities should be made and followed
at all places. Labels should be periodically checked for any
tear, removed label, or wrongly placed vial or ampoule (4).
There should be a closed loop verbal communication in-
volving the drug name and concentration made before ad-
ministrating the drug between the drugs providers in OT
(technician or resident) with the anesthetist in charge of
the case. The drug should be drawn by the same resident
who labels the syringe. It is desired that drugs should be
checked independently and verbally verified before filling
the syringe. Strict legible and bold labeled organization
of drug drawers should be considered with attention to
the position of ampoules and vials. Similar or dangerous
drugs should be segregated. Uncommonly used danger-
ous drugs should be separated from the commonly used
drugs. Timely internal audits by a specific team (drug
safety officer and/or a pharmacist) to recheck organization
of drugs and names should be employed. Similar pack-
aging and presentation of drugs should be avoided and
banned for further procurement by the hospital, where
possible. Use upper case letters to emphasize differences
in medications with sound-alike names to aid in distin-
guishing between the two. e.g., amLODIPine, amiTRIPTY-
Line, morphine, HYDROmorphine, etc. (5). Avoid abbre-
viations of drug names e.g. Atr for Atropine or, Atr for
Atracurium (muscle relaxant), creating confusion. Only
pre-decided ampoules should be kept for the case and re-
counting should be done at the end of each case to iden-
tify any medication errors and to take measures to avoid
future errors. Errors in intravenous drug administration
due to look-alike drugs should be reported and reviewed.
There should be time to time audits to minimize such er-
rors. These errors can be reduced and eliminated by re-
ducing physician working hours in OT due to the fact that
many such errors are bound to happen by a resident who
is fatigued or sleepy because of prolonged working hours.
Training residents, especially the newer trainees, should be
supervised by senior personnel in OT.
Despite advancement in anesthesiology principles and
management, drug errors are known to occur in opera-
tion theaters and ICU setting. Some of the drug errors
are minor, but some can cost a patient’s life. Errors creep-
ing from look-alike drugs can be easily prevented by vig-
ilance, surveillance, standardized coding, and protocol
along with a simple habit of reading the drug name twice
before loading the drug in the syringe.
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